Floatz logo

Metformin

Metabolism and Nutrition Disorder

Jinnah Sindh Medical UniversitySmall moleculePhase 4 / ApprovedActive
A
82/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
74/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Metabolism and Nutrition Disorder cohort.

Asset / SponsorPhaseRating
Liraglutide
Anders Fink-Jensen, MD, DMSci
Phase 4A
Semaglutide
Nordsjaellands Hospital
Phase 4A
nnc9204-0530
Novo Nordisk A/S
Phase 1CCC
nnc9204-1177
Novo Nordisk A/S
Phase 1CCC
nnc0165-1562
Novo Nordisk A/S
Phase 1CCC

View all 12 →

Same molecule, other indications

Metformin is also rated in:

gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
diabetes mellitusDormant
A
Indicative ·
80 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →